AAAAAA

   
Results: 1-15 |
Results: 15
WHEN ARE BIOAVAILABILITY STUDIES REQUIRED - A GERMAN PROPOSAL
Authors: GLEITER CH KLOTZ U KUHLMANN J BLUME H STANISLAUS F HARDER S PAULUS H
Citation: Ch. Gleiter et al., WHEN ARE BIOAVAILABILITY STUDIES REQUIRED - A GERMAN PROPOSAL, Journal of clinical pharmacology, 38(10), 1998, pp. 904-911
SPECIAL SECTION - BIOTECHNOLOGY IN DRUG RESEARCH - PREFACE
Authors: STANISLAUS F LAICHER A VONNIECIECKI A
Citation: F. Stanislaus et al., SPECIAL SECTION - BIOTECHNOLOGY IN DRUG RESEARCH - PREFACE, Arzneimittel-Forschung, 48(5A), 1998, pp. 534-534
INFLUENCE OF DIFFERENT VARIABLES ON THE IN-VITRO DISSOLUTION OF A SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORM
Authors: FUCHS WS JAKOBS R GRUNENBERG P WEISS G PROFITLICH T VONNIECIECKI A KLEMM FH LAICHER A STANISLAUS F
Citation: Ws. Fuchs et al., INFLUENCE OF DIFFERENT VARIABLES ON THE IN-VITRO DISSOLUTION OF A SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORM, Arzneimittel-Forschung, 48(5A), 1998, pp. 552-556
IN-VIVO VERIFICATION OF THE IN-VITRO RELEASE SPECIFICATION OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION
Authors: VONNIECIECKI A FUCHS WS PABST G MULLER M DILGER C GAY S LAICHER A STANISLAUS F
Citation: A. Vonnieciecki et al., IN-VIVO VERIFICATION OF THE IN-VITRO RELEASE SPECIFICATION OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION, Arzneimittel-Forschung, 48(5A), 1998, pp. 580-583
PHARMACOKINETICS OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION FOLLOWING ONCE-A-DAY AND TWICE-A-DAY MULTIPLE DOSING
Authors: FUCHS WS VONNIECIECKI A PABST G MULLER M DILGER C GAY S LAICHER A STANISLAUS F
Citation: Ws. Fuchs et al., PHARMACOKINETICS OF A SUSTAINED-RELEASE THEOPHYLLINE PREPARATION FOLLOWING ONCE-A-DAY AND TWICE-A-DAY MULTIPLE DOSING, Arzneimittel-Forschung, 48(5A), 1998, pp. 589-592
EFFECT OF CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION
Authors: FUCHS WS VONNIECIECKI A MOLZ KH POPESCU G WEIL A BARKWORTH MF GAY S LAICHER A STANISLAUS F
Citation: Ws. Fuchs et al., EFFECT OF CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION, Arzneimittel-Forschung, 48(5A), 1998, pp. 597-604
MANUFACTURE AND IN-VITRO CHARACTERIZATION OF A NEW LIQUID THEOPHYLLINE SUSTAINED-RELEASE DOSAGE FORM - SACHETS WITH MICROCAPSULES FOR THE PREPARATION OF A READY-TO-USE SUSTAINED-RELEASE SUSPENSION
Authors: WEISS G KLEMM FH FUCHS WS STANISLAUS F ZEMA M CALANCHI M
Citation: G. Weiss et al., MANUFACTURE AND IN-VITRO CHARACTERIZATION OF A NEW LIQUID THEOPHYLLINE SUSTAINED-RELEASE DOSAGE FORM - SACHETS WITH MICROCAPSULES FOR THE PREPARATION OF A READY-TO-USE SUSTAINED-RELEASE SUSPENSION, Arzneimittel-Forschung, 48(5A), 1998, pp. 604-612
EFFECT OF GALLBLADDER CONTRACTION INDUCED CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION
Authors: FUCHS WS VONNIECIECKI A MOLZ KH POPESCU G WEIL A BARKWORTH MF GAY S LAICHER A STANISLAUS F
Citation: Ws. Fuchs et al., EFFECT OF GALLBLADDER CONTRACTION INDUCED CHOLAGOGIA ON THE PHARMACOKINETIC PROFILE OF A SUSTAINED-RELEASE THEOPHYLLINE FORMULATION, Arzneimittel-Forschung, 46(12), 1996, pp. 1120-1126
SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .1. TEMPERATURE AND PH DEPENDENCY OF COACERVATE FORMATION
Authors: WEISS G KNOCH A LAICHER A STANISLAUS F DANIELS R
Citation: G. Weiss et al., SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .1. TEMPERATURE AND PH DEPENDENCY OF COACERVATE FORMATION, International journal of pharmaceutics, 124(1), 1995, pp. 87-96
SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .2. MICROENCAPSULATION OF IBUPROFEN
Authors: WEISS G KNOCH A LAICHER A STANISLAUS F DANIELS R
Citation: G. Weiss et al., SIMPLE COACERVATION OF HYDROXYPROPYL METHYLCELLULOSE PHTHALATE (HPMCP) .2. MICROENCAPSULATION OF IBUPROFEN, International journal of pharmaceutics, 124(1), 1995, pp. 97-105
PHARMACOKINETICS OF PHYSOSTIGMINE IN MAN FOLLOWING A SINGLE APPLICATION OF A TRANSDERMAL SYSTEM
Authors: WALTER K MULLER M BARKWORTH MF NIECIECKI AV STANISLAUS F
Citation: K. Walter et al., PHARMACOKINETICS OF PHYSOSTIGMINE IN MAN FOLLOWING A SINGLE APPLICATION OF A TRANSDERMAL SYSTEM, British journal of clinical pharmacology, 39(1), 1995, pp. 59-63
PHARMACOKINETICS OF IBUPROFEN FOLLOWING A SINGLE ADMINISTRATION OF A SUSPENSION CONTAINING ENTERIC-COATED MICROCAPSULES
Authors: WALTER K WEISS G LAICHER A STANISLAUS F
Citation: K. Walter et al., PHARMACOKINETICS OF IBUPROFEN FOLLOWING A SINGLE ADMINISTRATION OF A SUSPENSION CONTAINING ENTERIC-COATED MICROCAPSULES, Arzneimittel-Forschung, 45-2(8), 1995, pp. 886-890
BIOAVAILABILITY STUDY OF ENTERIC-COATED D ICLOFENAC FORMULATIONS .2. BIOAVAILABILITY STUDY FOLLOWING SINGLE-DOSE ADMINISTRATION OF A MULTIPLE-UNIT FORMULATION AND A SINGLE-UNIT FORMULATION COMPARING FASTED ANDNONFASTED CONDITIONS
Authors: SCHEIDEL B BLUME H WALTER K STANISLAUS F BABEJDOLLE RM
Citation: B. Scheidel et al., BIOAVAILABILITY STUDY OF ENTERIC-COATED D ICLOFENAC FORMULATIONS .2. BIOAVAILABILITY STUDY FOLLOWING SINGLE-DOSE ADMINISTRATION OF A MULTIPLE-UNIT FORMULATION AND A SINGLE-UNIT FORMULATION COMPARING FASTED ANDNONFASTED CONDITIONS, Arzneimittel-Forschung, 44-1(4), 1994, pp. 544-550
MICROENCAPSULATION OF IBUPROFEN BY A COACERVATION PROCESS USING EUDRAGIT L100-55 AS AN ENTERIC POLYMER
Authors: WEISS G KNOCH A LAICHER A STANISLAUS F DANIELS R
Citation: G. Weiss et al., MICROENCAPSULATION OF IBUPROFEN BY A COACERVATION PROCESS USING EUDRAGIT L100-55 AS AN ENTERIC POLYMER, Drug development and industrial pharmacy, 19(20), 1993, pp. 2751-2764
AQUEOUS COATING OF PELLETS TO SUSTAINED-RELEASE DOSAGE FORMS IN A FLUID-BED COATER - INFLUENCE OF PRODUCT TEMPERATURE AND POLYMER CONCENTRATION ON IN-VITRO RELEASE
Authors: LAICHER A LORCK CA GRUNENBERG PC KLEMM H STANISLAUS F
Citation: A. Laicher et al., AQUEOUS COATING OF PELLETS TO SUSTAINED-RELEASE DOSAGE FORMS IN A FLUID-BED COATER - INFLUENCE OF PRODUCT TEMPERATURE AND POLYMER CONCENTRATION ON IN-VITRO RELEASE, Pharmazeutische Industrie, 55(12), 1993, pp. 1113-1116
Risultati: 1-15 |